Home >> News and Information >>News Updates >> RPA CRISPR Technology: Principles, Applications, and Limitations Analysis
详细内容

RPA CRISPR Technology: Principles, Applications, and Limitations Analysis

The combined use of RPA (Recombinase Polymerase Amplification) technology and CRISPR technology is a very cutting-edge and popular combination in the field of nucleic acid detection at present. This combination of technologies represents the development direction of a new generation of nucleic acid diagnostic tools, with significant advantages such as rapid, sensitive, and portable.


The principle of combined use of RPA-CRISPR technology

The core logic of the technology portfolio

The core logic of the joint RPA-CRISPR technology is " division of labor and cooperation, strong alliance": RPA is responsible for rapidly and efficiently amplifying the target nucleic acid under constant temperature conditions (responsible for " increasing quantity"), while the CRISPR system is responsible for precisely identifying the amplified products and outputting signals (responsible for " precise confirmation"). This combination not only solves the problem of RPA being prone to non-specific amplification but also overcomes the shortcomings of traditional CRISPR detection in terms of sensitivity.

Step 1: RPA constant temperature amplification (fast replication of the target)

Specific principles refer to¡¶RPAAmplification Technology Principles¡£

After the RPA reaction, the trace amount of target DNA in the sample is rapidly amplified thousands of times, providing sufficient "ammunition" for the next step of detection.

Step 2: CRISPR/Cas system recognition and signal output (accurate confirmation and amplification)

In the case of combined detection, the most commonly used CRISPR system is Cas12a (some studies also use Cas13 or Cas12b, the principle is similar, and there are some differences in some of their properties). The Cas12a protein has two cutting activities:

InUvsation (specific recognition): Directed by a guide RNA (crRNA), Cas12a precisely locates and binds to the target DNA fragment amplified by RPA. Once recognition and binding are successful, Cas12a cuts the target DNA.

Trans-Cut (Attachment/Cut/Signal Amplification):This is the key to joint detection!Once Cas12a recognizes the target DNA and is activated, it enters a "mad cut" mode, starting to cut any single-stranded DNA (ssDNA) reporter molecule (Reporter) in the surrounding environment indiscriminately.

Signal generation mechanism

In the reaction system, scientists will add a single-stranded DNA probe in advance, one end of which is attached to a "fluorescent group" and the other end is attached to a "quencher group" (Cas13 is an RNA probe).

Non¼¤»î state: The fluorescent group and the quencher group are close together, and the fluorescence is quenched, no signal is detected.

After activation: Cas12a, activated by RPA products, cuts this probe, separating the fluorophore from the quencher, thus releasing a strong fluorescence signal. By detecting the fluorescence intensity, or by observing the color change of the strip on the lateral flow strip (LFA), it is possible to intuitively determine whether the sample contains the target pathogen.

Integration strategy

To perfectly combine these two steps, there are currently several main integration methods:

1. Two-tube method (step-wise detection): RPA amplification is performed in the first tube, and then the amplicons are manually transferred to the second tube containing CRISPR reagents for detection. This method allows each step to be independently optimized, but the disadvantage is that transfer with cap removal is prone to aerosol contamination (false positives).

2. One-pot: All the reagents of RPA and CRISPR are mixed in the same tube and allowed to react. To prevent CRISPR from cutting the amplified products before the amplification is completed, scientists have developed a clever strategy:

a) Orthogonal enzyme strategy: The use of different enzymes with different characteristics, such as Cas12a and Cas13, avoids interference with each other.

b) Temperature-Regulated Asynchronous Strategy (TRACE): Utilizing the temperature preference differences of different enzymes. For example, perform RPA and Cas12a at 37¡æ first (amplification and detection of the internal control), then increase the temperature to 60¡æ to perform Cas12b (detection of the pathogen), thus timing the reactions.

c) Chemical/enzymatic control strategy: A blocker is added at the beginning of the reaction to inhibit the activity of Cas12a, and Cas12a starts to work only after the RPA amplification accumulates to a certain amount, the blocker fails or is cut.

d) RNP control strategy: The formation rate of RNP is reduced by various means, thereby suppressing the activity of Cas12a at the beginning, and Cas12a starts to work only after a period of time for RPA amplification.


Potential risks and limitations of RPA-CRISPR technology

The inherent conflict in core reaction mechanisms ("space-time competition") is the biggest challenge this technology faces. There is a natural contradiction when RPA amplification and CRISPR detection are performed in the same reaction tube ("one-pot").

Premature cutting leads to a decrease in sensitivity: If the Cas12a protein is activated too early, it will directly cut the DNA template or primer that RPA is amplifying, resulting in the amplification reaction being suppressed, ultimately leading to a significant decrease in detection sensitivity.

Limitations of the decision strategy: Currently, although the activity of Cas12a can be delayed by using "suboptimal PAM sequences" (reducing the early binding ability of Cas12a) or chemically modifying the crRNA to gain time for RPA amplification, this requires cumbersome personalized screening and optimization for each detection target, increasing the difficulty of method development.

Pollution risk and operational complexity; aerosol contamination (false positive)

If the traditional "two-tube method" (amplication first, then the lid is opened to transfer to the detection tube) is adopted, the amplicon is very prone to form aerosol contamination of the laboratory environment, resulting in false positives in subsequent detection.

The cost and process of microfluidic chips: In order to solve the problem of pollution, the "space separation single-tube system" or "microfluidic chip" developed is able to achieve closed-tube detection, but the cost of precise processing of the chip is high, and the valve timing requirements for fluid control are extremely precise, which limits its large-scale popularization.

Multiple detection interference

When attempting to detect multiple pathogens in a single reaction (multiplexing), severe signal interference issues can arise.

Amplification competition: Multiple primers for RPA will compete for limited enzyme resources, resulting in reduced amplification efficiency for low-abundance targets.

Primer dimers and signal crosstalk: Primer dimers are easily formed between multiple pairs of primers, leading to false positives;

Meanwhile, the activated Cas12a may indiscriminately cut other target sites corresponding to reporter probes, leading to crosstalk.

Sample pretreatment and matrix interference

Nucleic acid extraction is a bottleneck in molecular POCT. The "speed" of the entire detection process is often hindered by cumbersome sample pre-processing (such as DNA extraction, proteinase K digestion). Although the rapid heating cracking method is fast, the purity of the extracted nucleic acids is low, and it may contain impurities that inhibit RPA or CRISPR reactions, thus affecting the sensitivity of the detection.

Effect of complex sample matrix: When detecting complex samples such as food (e.g., chicken, beef) or clinical whole blood, certain components in the sample may inhibit the activity of the enzyme, leading to unstable detection results.

Biology limitations

Limitations of the biological characteristics of the pathogen: Even if the detection method itself is sensitive enough, if the pathogen is extremely unevenly distributed or present in extremely low loads in the sample (e.g., spotted fever Rickettsia in blood, which is intermittently present in low loads), a single test may still yield a negative result, not due to a technical defect, but rather a diagnostic limitation imposed by the biological characteristics of the disease itself.


Future Prospects

RPA-CRISPR technology, as a new generation of nucleic acid diagnostic tools, has shown great application potential in the fields of infectious disease diagnosis, food safety testing, and environmental monitoring, with its rapid, sensitive, and portable characteristics. This technology combines the constant temperature amplification of RPA and the precise recognition of CRISPR, achieving a revolutionary breakthrough in nucleic acid detection.

However, the technology still faces challenges such as conflicts in the reaction mechanism, pollution risk, multiple detection interference, sample processing bottlenecks, and cost constraints in practical applications. With the continuous development of orthogonal enzyme strategies, chemical modifications of crRNA, and microfluidic integration technologies, these limitations are being gradually overcome.

In the future, RPA-CRISPR technology will develop towards more stability, lower cost, and higher throughput, and ultimately become an ideal tool truly applicable to grassroots medical institutions and point-of-care testing (POCT), making significant contributions to global public health and precision medicine.

Through continuous technological innovation and engineering improvement, RPA-CRISPR technology is expected to become the mainstream platform for next-generation nucleic acid detection, providing strong technical support for human health and disease prevention and control.




Kang Gen Gene can provide you with a full set of RPA products, services and solutions, and we welcome you to contact us at any time!


customer service

Technical Service

Contact number

Company Address: Optics Valley Biotech City, Donghu High tech Zone, Wuhan City

Company email: dangkangbio@163.com

18162635786

seo seo